|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09606 DUALITYBIO-B
Nominal 
283.200 -15.200 (-5.094%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | |
| Turnover | 1,941,257 | 8.660% | 1,786,540 |
| Cost of Sales | (1,156,590) | 170.449% | (427,655) |
| Gross Profit | 784,667 | -42.257% | 1,358,885 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | |
| Change in FV & Impairment on Others | (873,416) | -14.194% | (1,017,899) | |
| Profit / (Loss) on Disposal | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | |
| Profit / (Loss) before Taxation | (1,014,546) | 401.632% | (202,249) | |
| Taxation | (35,888) | -76.886% | (155,263) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | |
| Others | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (1,050,434) | 193.818% | (357,512) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (47,862) | 39.560% | (34,295) |
| Depreciation & Amortisation | 7,870 | 57.810% | 4,987 |
| Directors' Emoluments | 94,260 | 328.065% | 22,020 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | |
| EPS (cts) | -- | -- | -- |
| DPS (cts) | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- |
| NBV per share ($) | -- | -- | -- |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -2,073,865 |
| %Change | 606.747% |
| EPS / (LPS) | RMB -49.700 |
| NBV Per Share (¥) | RMB 33.086 |